Mona Ashiya

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mona Ashiya
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Mona Ashiya

Form 4 holding Director

Disc Medicine, Inc.

Security class
Common Stock
Shares / value
186,541
Estimated value
$10,093,734
Report date
24 Mar 2025
Price
$54.11
Ownership
Indirect
Form 4 holding Director

Shattuck Labs, Inc.

Security class
Pre-Funded Warrants (right to buy)
Shares / value
5,303,908
Estimated value
Report date
11 Jun 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Shattuck Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
81,000
Estimated value
Report date
29 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Disc Medicine, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
10,000
Estimated value
Report date
11 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Shattuck Labs, Inc.

Security class
Common Warrants (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Sierra Oncology, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
$55.00
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Sierra Oncology, Inc.

Security class
Series A Warrants
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Sierra Oncology, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
01 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mona Ashiya

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .